Stocks to watch: Zee Entertainment, Radico Khaitan, Ashok Leyland, Zydus Lifesciences, TVS Motors, and Ultratech Cement

2 months ago 43

Zee Entertainment launched a $239 million Foreign Currency Convertible Bonds issue. Glenmark Pharmaceuticals received US FDA approval for generic Topiramate Capsules, targeting a $21.9 million market. Zydus Lifesciences signed a patent licensing deal with Takeda for the gastrointestinal drug ‘Vault’ (Vonoprazan). TVS Motors’ Norton Motorcycles plans to launch six new products and expand internationally. Radico Khaitan introduced the award-winning Sangam World Malt Whisky to the Indian market read more

 Zee Entertainment, Radico Khaitan, Ashok Leyland, Zydus Lifesciences, TVS Motors, and Ultratech Cement

The Indian stock market is likely to open in the red on July 18. Image source: Pixabay

The GIFT Nifty index on Thursday around 9 am was down 70 points or 0.28 per cent at 24,635.5. It hinted at a negative start for Dalal Street. The India VIX, an indicator of market volatility, was up 0.25 per cent or 14.22 points.

Ahead of the stock market opening in India, here’s a look at stocks to watch:
Zee Entertainment:
Zee Entertainment Enterprises announced on Tuesday (July 16) that it has launched a Foreign Currency Convertible Bonds (FCCB) issue aiming to raise $239 million. The company’s board approved raising funds by issuing unsecured, unlisted FCCBs with a 5 per cent coupon rate, up to $239 million, maturing in 10 years.

Glenmark Pharmaceuticals: Glenmark Pharma has secured final approval from the US FDA for its generic Topiramate Capsules USP, 15 mg and 25 mg, deemed bioequivalent to Janssen Pharmaceuticals’ Topamax Capsules. Topamax is a prescription medication primarily used to treat epilepsy and prevent migraines. Glenmark’s versions will be distributed in the US by Glenmark Pharmaceuticals Inc., USA, entering a market with annual sales of approximately $21.9 million, the company said in a press release on Wednesday (July 17).

Zydus Lifesciences: the company on July 17 announced a non-exclusive patent licensing agreement with Takeda for ‘Vault’ (Vonoprazan) in India. Vonoprazan is a novel gastrointestinal drug and is a next-generation treatment for gastro duodenal ulcers and Gastroesophageal Reflux Disease (GERD).

TVS Motors: Norton Motorcycles, which is part of the TVS Motor Company, has announced plans to launch six new products in the next three years. The British two-wheeler manufacturer is gearing up for international expansion, initially targeting the USA, Germany, France, Italy, and India.

TVS Motor has pledged to invest £200 million in new product development, facilities, research and development, and quality engineering.

Radico Khaitan: Radico Khaitan has introduced the award-winning Sangam World Malt Whisky to the Indian market. Launched just a year ago, Sangam has already garnered international acclaim.

Ultratech Cement: Ultratech Cement has entered into a Power Purchase Agreement and Share Subscription and Shareholders Agreement to acquire a 26 per cent equity stake in Amplus Omega Solar Private Limited, a renewable energy company. The acquisition aims to meet Ultratech’s green energy requirements, optimise energy costs, and comply with regulatory mandates for captive power consumption under electricity laws.

Ashok Leyland: Hinduja Tech Limited, a subsidiary of Ashok Leyland under the Hinduja Group, has signed a definitive agreement to acquire TECOSIM Group. This acquisition grants Hinduja Tech a strategic foothold in Europe, broadening its geographic reach and providing access to key customer accounts.

Zensar Technologies: Zensar Technologies Inc., USA, a wholly owned subsidiary of Zensar Technologies Limited, has signed a definitive agreement to acquire BridgeView Life Sciences, LLC. BridgeView specialises in technology consulting and system integration services for biopharma and life sciences customers, bolstering Zensar’s capabilities in these sectors.

Read Entire Article